360 High-Risk Vulnerability Immunization Tool V2.0 vs EnProbe Cybersecurity: Side-by-Side Comparison (2026)

360 High-Risk Vulnerability Immunization Tool V2.0

Startups and SMBs with Windows-heavy infrastructure and patching backlogs should run 360 High-Risk Vulnerability Immunization Tool V2.0 first; it immunizes against the specific CVEs that drive ransomware campaigns (MS17-010, CVE-2019-0708) without requiring immediate OS updates. The tool supports Windows 7 through current versions and deploys on-premises, meaning air-gapped networks can actually use it. Skip this if you're looking for NIST PR.PS coverage beyond platform hardening,this tool stops known exploits, not supply chain attacks or firmware-level threats.

EnProbe Cybersecurity

Startups and SMBs with lightweight development teams should pick EnProbe Cybersecurity for fast, language-agnostic web app scanning without the overhead of on-premise infrastructure or per-page licensing traps. The tool scans 100+ attack vectors including OWASP Top 10 and handles AJAX/JavaScript sites that simpler scanners miss, covering both ID.RA risk assessment and PR.PS platform security in the NIST CSF. Skip this if you need integrated SAST/DAST or deep API security; EnProbe is web application vulnerability assessment only, not a broader AppSec platform.